Adverse drug reactions (ADRs) include 2 types, namely types A and B. Type A ADRs include overdose toxicity, commonly observed side effects, indirect effects, and drug-drug interactions based on a drug's inherent pharmacological action. Type B ADRs include intolerance, drug idiosyncrasy, drug hypersensitivity reactions (DHRs) caused by immunological mechanisms and pseudoallergic reactions caused by nonimmune mechanisms \[[@b1-cep-2019-01487]\]. A DHR is a drug-mediated immunological mechanism in sensitized patients and occurs in a narrow sense in combination with drug allergies (DAs) \[[@b2-cep-2019-01487]\].

The clinical manifestation of DA is variable; sometimes children already have various diseases when suspected allergic symptoms occur. In children, respiratory and gastrointestinal symptoms, along with skin symptoms, are the most common allergic symptoms, which are like those of the underlying disease for which the drug is administered. Therefore, clinicians may miss some DAs. Moreover, clinicians diagnose DAs according to drug administration history alone without performing a diagnostic evaluation.

Drug provocation tests (DPTs) and skin tests were previously performed for suspected DAs in 43 children who were assessed by physicians to have DHRs. Among them, however, DHRs were confirmed only in 3 patients \[[@b3-cep-2019-01487]\]. The DPTs were positive in about 25%--30% of children with suspected DHR \[[@b4-cep-2019-01487],[@b5-cep-2019-01487]\]. These results differed from those suspected clinically and those confirmed by diagnostic evaluation. The diagnosis of DA based on medical history alone is vague and unreliable, leading to overdiagnosis. Limiting the prescriptions of drugs causing suspected DAs without a definite diagnosis restricts the number of alternative drugs, especially in children who have fewer approved options than adults. It is important to accurately diagnose a DA because difficulty selecting appropriate drugs can result in less effective treatment and the need for subsequent treatment, which in turn can increase medical costs.

This review of drug allergies in children \[[@b6-cep-2019-01487]\] highlights a wide range of topics, including DA epidemiology, the causative agent, and diagnostic methods. When diagnosing DA, history taking and examination are important to determining suspected diseases and drugs. Furthermore, objective tests such as skin tests, DPTs, and serum tests are performed. To accurately diagnose DA, it is necessary to confirm that it is a symptom of an immunological mechanism of a drug response. However, unlike tests for determining the causes of other allergies, tests to measure serum-specific immunoglobulin E (IgE) for drugs in DAs are not commercially available, except for specific IgE for a few drugs \[[@b6-cep-2019-01487]\]. Some *in vitro* tests (basophil activation test and lymphocyte transformation test) are difficult to perform in clinical practice. The most commonly used methods for DA diagnosis are skin tests and DPT. However, the skin prick test and intradermal test have limitations that a negative result can occur in cases of a non-IgE-mediated ADR. Intradermal tests cannot be easily performed in children due to pain and difficulty. Therefore, DPTs are useful in the diagnosis of DA in children \[[@b4-cep-2019-01487]-[@b6-cep-2019-01487]\].

The major causative drugs of ADR in children are antibiotics, especially beta-lactams; nonsteroidal anti-inflammatory drugs; and vaccines \[[@b6-cep-2019-01487],[@b7-cep-2019-01487]\]. DAs can be suspected when a symptom develops after drug administration, and the suspected drug can be selected and subjected to further evaluation. It is important to distinguish between immediate and nonimmediate reactions by checking the time to symptom onset after drug administration. While selecting a diagnostic test method, history taking is important. A detailed history in patients with a suspected DA was well documented in this review, which may be of great help in clinical practice.

When a DA is suspected, it is important to pinpoint the cause, the identification of which can help prevent the development of allergic symptoms. It is also important to be aware of DA and avoid prescribing medications that cause allergies. Although the diagnosis of DA depends on medical history and there are few standardized tests, identifying the causative agent of DA is very important in preventing its occurrence. In this regard, the review of Park and Suh \[[@b6-cep-2019-01487]\] explains the current knowledge of DA in children, which seems to be of great help in its diagnosis and prevention in pediatric patients.

See the article "Drug allergy in children: what should we know?" via <https://doi.org/10.3345/kjp.2019.00675>.
